Clinics in Dermatology
Volume 26, Issue 5 , Pages 486-502, September 2008

Tumor necrosis factor antagonists in the therapy of psoriasis☆

  • Rotraut Mössner, MD

      Affiliations

    • Department of Dermatology, Georg-August University, von-Siebold-Str. 3, 37075 Göttingen, Germany
    • ,
  • Michael P. Schön, MD

      Affiliations

    • Rudolf Virchow Center, Deutsche Forschungsgemeinschaft Research Center for Experimental Biomedicine, Versbacher Str 9, 97078 Würzburg, Germany
    • Department of Dermatology, University of Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany
    • Department of Dermatology and Venerology, University Medical Center Göttingen, von-Siebold Str 3, 37075 Göttingen, Germany
    • ,
  • Kristian Reich, MD

      Affiliations

    • Department of Dermatology, Georg-August University, von-Siebold-Str. 3, 37075 Göttingen, Germany
    • Dermatologikum, Stephansplatz 5, 20354 Hamburg, Germany
    • Corresponding Author InformationCorresponding author. Dermatologikum Hamburg, Stephansplatz 5, 20354 Hamburg, Germany. Tel.: +49 0 551 396427; fax: +49 0 551 396418.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ R. M. has received travel grants from Essex (Munich, Germany) and Wyeth (Münster, Germany). M. P. S. has received lecture fees from Serono (Munich, Germany), Wyeth, Essex, and Abbott (Wiesbaden, Germany), and research grants from Schering/Berlex (Richmond, Calif). K. R. has served as a consultant and paid speaker for Abbott, Biogen Idec (Tsamaning, Germany), Centocor (Horsham, PA), Essex, Schering-Plough (Kenilworth, NJ), Serono, and Wyeth. He has also received grant funding from Biogen Idec.

PII: S0738-081X(07)00254-4

doi:10.1016/j.clindermatol.2007.10.030

Clinics in Dermatology
Volume 26, Issue 5 , Pages 486-502, September 2008

Article Tools

* Image Usage & Resolution